Literature DB >> 31104739

Real-World Evidence, Causal Inference, and Machine Learning.

William H Crown1.   

Abstract

The current focus on real world evidence (RWE) is occurring at a time when at least two major trends are converging. First, is the progress made in observational research design and methods over the past decade. Second, the development of numerous large observational healthcare databases around the world is creating repositories of improved data assets to support observational research.
OBJECTIVE: This paper examines the implications of the improvements in observational methods and research design, as well as the growing availability of real world data for the quality of RWE. These developments have been very positive. On the other hand, unstructured data, such as medical notes, and the sparcity of data created by merging multiple data assets are not easily handled by traditional health services research statistical methods. In response, machine learning methods are gaining increased traction as potential tools for analyzing massive, complex datasets.
CONCLUSIONS: Machine learning methods have traditionally been used for classification and prediction, rather than causal inference. The prediction capabilities of machine learning are valuable by themselves. However, using machine learning for causal inference is still evolving. Machine learning can be used for hypothesis generation, followed by the application of traditional causal methods. But relatively recent developments, such as targeted maximum likelihood methods, are directly integrating machine learning with causal inference.
Copyright © 2019 ISPOR–The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved.

Keywords:  big data; causal inference; econometrics; epidemiology; machine learning; real-world evidence; targeted maximum likelihood estimator

Mesh:

Year:  2019        PMID: 31104739     DOI: 10.1016/j.jval.2019.03.001

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  7 in total

Review 1.  Public Health Impact of Using Biosimilars, Is Automated Follow up Relevant?

Authors:  Antoine Perpoil; Gael Grimandi; Stéphane Birklé; Jean-François Simonet; Anne Chiffoleau; François Bocquet
Journal:  Int J Environ Res Public Health       Date:  2020-12-29       Impact factor: 3.390

Review 2.  Context and Considerations for Use of Two Japanese Real-World Databases in Japan: Medical Data Vision and Japanese Medical Data Center.

Authors:  Thomas Laurent; Jason Simeone; Ryohei Kuwatsuru; Takahiro Hirano; Sophie Graham; Ryozo Wakabayashi; Robert Phillips; Tatsuya Isomura
Journal:  Drugs Real World Outcomes       Date:  2022-03-18

3.  Effectiveness of Prophylactic Use of Hepatoprotectants for Tuberculosis Drug-Induced Liver Injury: A Population-Based Cohort Analysis Involving 6,743 Chinese Patients.

Authors:  Qin Chen; Airong Hu; Aixia Ma; Feng Jiang; Yue Xiao; Yanfei Chen; Ruijian Huang; Tianchi Yang; Jifang Zhou
Journal:  Front Pharmacol       Date:  2022-04-20       Impact factor: 5.810

Review 4.  Analyzing Precision Medicine Utilization with Real-World Data: A Scoping Review.

Authors:  Michael P Douglas; Anika Kumar
Journal:  J Pers Med       Date:  2022-04-01

5.  Artificial Intelligence, Real-World Automation and the Safety of Medicines.

Authors:  Andrew Bate; Steve F Hobbiger
Journal:  Drug Saf       Date:  2020-10-07       Impact factor: 5.606

Review 6.  Randomized Trials Versus Common Sense and Clinical Observation: JACC Review Topic of the Week.

Authors:  Alexander C Fanaroff; Robert M Califf; Robert A Harrington; Christopher B Granger; John J V McMurray; Manesh R Patel; Deepak L Bhatt; Stephan Windecker; Adrian F Hernandez; C Michael Gibson; John H Alexander; Renato D Lopes
Journal:  J Am Coll Cardiol       Date:  2020-08-04       Impact factor: 24.094

7.  Artificial intelligence with multi-functional machine learning platform development for better healthcare and precision medicine.

Authors:  Zeeshan Ahmed; Khalid Mohamed; Saman Zeeshan; XinQi Dong
Journal:  Database (Oxford)       Date:  2020-01-01       Impact factor: 3.451

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.